Panagora Asset Management’s Intermolecular, Inc. IMI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-33,706
| Closed | -$39K | – | 2774 |
|
|
2019
Q2 | $39K | Sell |
33,706
-875
| -3% | -$1K | ﹤0.01% | 2140 |
|
|
2019
Q1 | $40K | Hold |
34,581
| – | – | ﹤0.01% | 2100 |
|
|
2018
Q4 | $35K | Sell |
34,581
-563
| -2% | -$565 | ﹤0.01% | 2069 |
|
|
2018
Q3 | $41K | Buy |
35,144
+26,595
| +311% | +$38K | ﹤0.01% | 2063 |
|
|
2018
Q2 | $14K | Buy |
+8,549
| New | +$11.7K | ﹤0.01% | 2234 |
|
|
2017
Q3 | – | Sell |
-48,786
| Closed | -$45K | – | 2603 |
|
|
2017
Q2 | $45K | Sell |
48,786
-2,646
| -5% | -$2.31K | ﹤0.01% | 2095 |
|
|
2017
Q1 | $48K | Hold |
51,432
| – | – | ﹤0.01% | 2028 |
|
|
2016
Q4 | $49K | Hold |
51,432
| – | – | ﹤0.01% | 2107 |
|
|
2016
Q3 | $51K | Buy |
+51,432
| New | +$63.4K | ﹤0.01% | 2107 |
|
|
2013
Q4 | – | Sell |
-39,884
| Closed | -$220K | – | 2293 |
|
|
2013
Q3 | $220K | Buy |
39,884
+11,288
| +39% | +$71K | ﹤0.01% | 1634 |
|
|
2013
Q2 | $208K | Buy |
+28,596
| New | +$243K | ﹤0.01% | 1622 |
|
Panagora Asset Management's IMI Position: Q3 2019 in Review
Panagora Asset Management sold out of Intermolecular, Inc. (IMI) in Q3 2019, closing a stake of 33,706 shares — an estimated $39K sold.
Panagora Asset Management first reported a position in IMI in Q2 2013 and held it in 11 quarters. The position peaked at $220K in Q3 2013. 0 funds tracked by Wall St. Rank hold IMI as of Q3 2019.
- Panagora Asset Management reported no remaining Intermolecular, Inc. position as of Q3 2019 after selling out during the quarter.
- Panagora Asset Management sold 33,706 Intermolecular, Inc. shares in Q3 2019, an estimated $39K.
- Panagora Asset Management first reported a position in Intermolecular, Inc. in Q2 2013 and held it in 11 quarters.
- Panagora Asset Management's Intermolecular, Inc. position peaked at $220K in Q3 2013.
- 0 funds tracked by Wall St. Rank held Intermolecular, Inc. as of Q3 2019.
Based on Panagora Asset Management's 13F filing for Q3 2019, filed 12 Nov 2019.